Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation By: Benzinga via Benzinga March 13, 2023 at 13:18 PM EDT Bristol Myers Squibb & Co's(NYSE: BMY) Eliquis,Pfizer Inc's(NYSE: PFE) Ibrance, andAbbVie ... Read More >> Related Stocks: AbbVie Astellas Pharma Inc Bristol-Myers Squibb Johnson & Johnson Novo Nordisk A/S Common Stock Pfizer